GlassScriptPhysician profile
Jeanne Yu
NPI 1528086956
$798.48
in general payments reported to CMS, 2019-2025
14 companies · $175 in 2025
The $175 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $61.91 · 2021: $47.47 · 2022: $98.63 · 2023: $109 · 2024: $85.08 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $368.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $212.40 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $155.35 | 2020-2025 | Entyvio |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $110.63 | 2022-2024 | Plenvu, Xifaxan |
| Braintree Laboratories, INC. | $83.43 | 2023-2025 | Sutab, Suflave |
| Abbvie INC. | $40.29 | 2020 | |
| Olympus America INC. | $34.02 | 2023 | Long Clip, Olympus Endotherapy Inflation Device For Endoscopic Balloon Dilation |
| Medtronic, INC. | $32.51 | 2025 | Signia |
| Ardelyx, INC. | $24.51 | 2025 | Ibsrela |
| Laborie Medical Technologies Corp. | $23.85 | 2023 | |
| Tetraphase Pharmaceuticals, INC. | $20.46 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.25 | 2025 | Dupixent |
| Janssen Biotech, INC. | $16.51 | 2023 | Stelara |
| Ethicon US, LLC | $15.00 | 2025 | Echelon Circular |
| Tela Bio, INC. | $12.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeanne Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.